Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunteers
Clinical trial NCT05124717 · COMPLETED
Trial details
- NCT number
- NCT05124717
- Sponsor
- Joint Stock Company "Farmak"
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2019-07-03
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.